局部晚期直肠癌术前及术后辅助放疗的应用调查与研究

发布时间：2018-06-10 11:34

本文选题：直肠肿瘤 + 综合治疗　；参考：《苏州大学》2016年硕士论文

【摘要】：目的探讨2010年卫生部医政司发布《结直肠癌诊疗规范》以来国内地市级医院直肠癌综合治疗的现状。方法通过门诊、电话、信函等方式随访2010年1月至2013年12月在我院接受根治性手术治疗的直肠癌患者,调查其接受《结直肠癌诊疗规范》制定的新辅助治疗或术后辅助治疗的状况。结果所有接受手术治疗,并经病理证实的直肠癌患者共438例,仅有9例患者接受了术前放疗;随访到的有术后放疗指征(T3/4N0M0或TxN1-2M0)的患者293例,接受单纯术后放疗18人(6.1%),术后同步放化疗者为33人(11.3%),有242人(82.6%)未接受术后放疗,其中医务人员没有履行相应的告知义务的为173人,占71.5%。结论一些临床医生对综合治疗的理解和认识还存在偏差。特别是新辅助治疗的应用,还有许多值得探讨和规范之处。
[Abstract]:Objective to investigate the current situation of comprehensive treatment of colorectal cancer in municipal hospitals since 2010, issued by Department of Medical Affairs of the Ministry of Health. Methods from January 2010 to December 2013, patients with rectal cancer undergoing radical surgical treatment in our hospital were followed up by outpatient, telephone and letter. To investigate the status of neoadjuvant therapy or postoperative adjuvant therapy for colorectal cancer. Results there were 438 cases of rectal cancer treated by surgery and confirmed by pathology, only 9 cases received preoperative radiotherapy, 293 cases were followed up with the indication of postoperative radiotherapy: T3 / 4N0M0 or TxN1-2M0). 18 patients received postoperative radiotherapy alone, 33 patients received concurrent radiotherapy and chemotherapy, and 242 patients received radiotherapy without postoperative radiotherapy. Among them, 173 patients (71.5%) did not perform the corresponding notification obligation. Conclusion there are still some deviations in the understanding and understanding of comprehensive therapy among some clinicians. Especially, the application of neoadjuvant therapy is worth discussing and standardizing.
【学位授予单位】：苏州大学
【学位级别】：硕士
【学位授予年份】：2016
【分类号】：R735.37

【相似文献】